Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDExagen Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 2 | -$0.22 | -$0.19 | -$0.20 |
| Q2 2025 | 5 | -$0.18 | -$0.12 | -$0.15 |
| Q3 2025 | 3 | -$0.17 | -$0.14 | -$0.16 |
| Q4 2025 | 3 | -$0.19 | -$0.17 | -$0.18 |
| Q1 2026 | 3 | -$0.15 | -$0.15 | -$0.15 |
| Q2 2026 | 1 | -$0.13 | -$0.11 | -$0.12 |
| Q3 2026 | 1 | -$0.12 | -$0.10 | -$0.11 |
| Q4 2026 | 1 | -$0.10 | -$0.08 | -$0.09 |
| Q1 2027 | 1 | -$0.07 | -$0.06 | -$0.06 |
| Q2 2027 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q3 2027 | 1 | $0.03 | $0.03 | $0.03 |
| Q4 2027 | 1 | $0.06 | $0.07 | $0.07 |
Exagen Inc. Earnings Date And Information
Exagen Inc. last posted its earnings results on Tuesday, November 4th, 2025. The company reported $-0.19 earnings per share for the quarter, missing analysts' consensus estimates of $-0.13 by $0.06. The company had revenue of 17.24 M for the quarter and had revenue of 55.64 M for the year. Exagen Inc. has generated $-1 earnings per share over the last year ($-0.83 diluted earnings per share) and currently has a price-to-earnings ratio of -8.94. Exagen Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 10th, 2026 based on prior year's report dates.
Exagen Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/04/2025 | Q3 2025 | -$0.13 | -$0.31 | -0.18 | $16.88 M | $17.24 M |
| 07/29/2025 | Q2 2025 | -$0.18 | -$0.21 | -0.03 | $16.31 M | $17.20 M |
| 05/05/2025 | Q1 2025 | -$0.20 | -$0.20 | 0 | N/A | $15.50 M |
| 03/11/2025 | Q4 2024 | -$0.27 | -$0.20 | 0.07 | N/A | $13.66 M |
| 11/12/2024 | Q3 2024 | -$0.30 | -$0.28 | 0.02 | $13.57 M | $12.51 M |
| 08/05/2024 | Q2 2024 | -$0.36 | -$0.16 | 0.2 | $13.13 M | $15.06 M |
| 05/13/2024 | Q1 2024 | -$0.40 | -$0.19 | 0.21 | N/A | $14.42 M |
| 03/18/2024 | Q4 2023 | -$0.41 | -$0.31 | 0.1 | N/A | $13.77 M |
| 11/13/2023 | Q3 2023 | -$0.50 | -$0.31 | 0.19 | $10.33 M | $13.42 M |
| 08/07/2023 | Q2 2023 | -$0.48 | -$0.28 | 0.2 | $10.93 M | $14.14 M |
| 05/15/2023 | Q1 2023 | -$0.52 | -$0.44 | 0.08 | $9.41 M | $11.23 M |
| 03/20/2023 | Q4 2022 | -$0.71 | -$0.83 | -0.12 | $8.66 M | $12.84 M |
| 11/21/2022 | Q3 2022 | N/A | -$0.47 | N/A | $9.05 M | $14.73 M |
| 08/04/2022 | Q2 2022 | -$0.55 | -$0.86 | -0.31 | $12.03 M | $7.61 M |
| 05/11/2022 | Q1 2022 | -$0.59 | -$0.60 | -0.01 | $10.00 M | $10.39 M |
| 03/22/2022 | Q4 2021 | -$0.49 | -$0.42 | 0.07 | $11.71 M | $12.69 M |
| 11/10/2021 | Q3 2021 | -$0.43 | -$0.42 | 0.01 | $12.13 M | $12.25 M |
| 08/09/2021 | Q2 2021 | -$0.50 | -$0.38 | 0.12 | $11.48 M | $12.77 M |
| 05/11/2021 | Q1 2021 | -$0.46 | -$0.48 | -0.02 | $10.45 M | $10.59 M |
| 03/16/2021 | Q4 2020 | -$0.33 | -$0.27 | 0.06 | $10.69 M | $12.67 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Exagen Inc. Earnings: FAQ's
Exagen Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 10th, 2026 based offlast year's report dates.
The conference call for Exagen Inc.'s latest earnings report can be listened to online.
The conference call transcript for Exagen Inc.'s latest earnings report can be read online.
Exagen Inc. (:XGN) has a recorded annual revenue of $55.64 M.
Exagen Inc. (:XGN) has a recorded net income of $-15,115,000.Exagen Inc. has generated $-0.83 earnings per share over the last four quarters.
Exagen Inc. (:XGN) has a price-to-earnings ratio of -8.94 and price/earnings-to-growth ratio is 1.5.